Business
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
ELMWOOD PARK, N.J., Nov. 28, 2023 /PRNewswire/ -- BioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic
About this update from Opko Health, Inc.
[{"type":"text","content":"ELMWOOD PARK, N.J., Nov. 28, 2023 /PRNewswire/ -- BioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data (\"RWD\") for the pharmaceutical and life science industries. This collaborative arrangement will offer healthcare providers and researchers unique solutions to inform clinical studies and improve patient outcomes. Combining genetic data and critical biomarkers, means targeted precision therapies based on patients' genetic profiles will be more readily available. \n\nBioReference and Prognos collaborate to offer healthcare providers and researchers unique RWD solutions.The collaboration combines BioReference Health's expertise in genomic data analysis with Prognos Health's managed RWD marketplace. Prognos is accelerating the development and delivery of innovative therapies and provides an unparalleled collection of health records on more than 325 million de-identified patient health records. Adding genomics will create even more solutions for patients and healthcare providers.\n\"Precision medicine holds immense potential to transform healthcare outcomes, and this agreement comes at a time when the global healthcare industry is recognizing the immense value of RWD in advancing precision medicine,\" said Anuj Kalsy, Lead, Data & Strategy, and Sr. Director of Pharmaceutical Arrangements at BioReference Health. \"Our collaboration with Prognos Health allows us to unlock the full potential of genomics and a comprehensive RWD marketplace to bring us closer to a future where personalized treatments are the norm.\"\n\"We are thrilled to collaborate with BioReference Health, a leader in genomic data and laboratory analytics,\" added Sundeep Bhan, CEO of Prognos Health. \"Together, we intend to harness the power of actionable data to accelerate drug discovery, help enable more effective diagnostics, and enhance decision-making throughout the pharmaceutical and life sciences domains and ultimately improve patient outcomes.\"\nAbout BioReference Health, LLCBioReference® Health LLC, an OPKO Health, Inc. Company (NASDAQ: OPK), empowers confident healthcare decisions by prioritizing service, creating innovative solutions, and offering scientific expertise in oncology, urology, and women's health...